| |
|
|
|
|
|
|
|||
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2446-2454. Prepublished online as a Blood First Edition Paper on June 6, 2006; DOI 10.1182/blood-2006-02-002204.
STEM CELLS IN HEMATOLOGY Clonal analysis of thymus-repopulating cells presents direct evidence for self-renewal division of human hematopoietic stem cellsFrom the Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa; the Department of Hematology, Tokai University School of Medicine, Isehara, Kanagawa; the Central Institute for Experimental Animals, Kawasaki, Kanagawa; the BioResource Center, RIKEN Tsukuba Institute, Tsukuba, Ibaraki; and the Department of Cell Transplantation & Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
To elucidate the in vivo kinetics of human hematopoietic stem cells (HSCs), CD34+CD38 cells were infected with lentivirus vector and transplanted into immunodeficient mice. We analyzed the multilineage differentiation and self-renewal abilities of individual thymus-repopulating clones in primary recipients, and their descending clones in paired secondary recipients, by tracing lentivirus gene integration sites in each lymphomyeloid progeny using a linear amplification-mediated polymerase chain reaction (PCR) strategy. Our clonal analysis revealed that a single human thymus-repopulating cell had the ability to produce lymphoid and myeloid lineage cells in the primary recipient and each secondary recipient, indicating that individual human HSCs expand clonally by self-renewal division. Furthermore, we found that the proportion of HSC clones present in the CD34+ cell population decreased as HSCs replicated during extensive repopulation and also as the differentiation capacity of the HSC clones became limited. This indicates the restriction of the ability of individual HSCs despite the expansion of total HSC population. We also demonstrated that the extensive self-renewal potential was confined in the relatively small proportion of HSC clones. We conclude that our clonal tracking studies clearly demonstrated that heterogeneity in the self-renewal capacity of HSC clones underlies the differences in clonal longevity in the CD34+ stem cell pool.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||